Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks

Human Reproduction

Volumn 14, Issue 11, 1999, Pages 2681-2686

  Fauser, Bart C J M ^a   Devroey, Paul ^b   Yen, Sam S C ^c   Gosden, Roger ^d   Crowley, William F ^e   Baird, David T ^f   Bouchard, Philippe ^g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN;

CRYOPRESERVATION; EDITORIAL; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MENSTRUAL CYCLE; MULTIPLE PREGNANCY; OVARY CANCER; OVULATION INDUCTION;

EID: 0032731623     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/14.11.2681     Document Type: Editorial

References (78)

1. Aboulghar, M.A., Mansour, R.T., Serour, G.I. and Rizk, B. (1996) Ovarian hyperstimulation syndrome: Modern concepts in pathophysiology and management. ME Fertil Soc J, 1, 3-16.
2. Agarwal, R., Tan, S.L., Wild, S. et al. (1999) Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil. Steril. 71, 287-293.
3. Akande, A.V., Mathur, R.S., Keay, S.D. and Jenkins, J.M. (1996) The choice of luteal support following pituitary down regulation, controlled ovarian hyperstimulation and in vitro fertilization. Br. J. Obstet. Gynaecol. 103, 963-966.
4. Andereck, W.S., Thomasma, D.C., Goldworth, A. and Kushner, T. (1998) The ethics of guaranteeing patient outcomes. Fertil. Steril. 70, 416-421.
5. Baird, D.T. (1990) The selection of the follicle of the month. In Evers, J.L.H. and Heineman, M.J. (eds), From Ovulation to Implantation. Excerpta Medica, Amsterdam etc. pp. 3-19.
6. Baird, T.D. and Pearson, S.J. (1998) Factors determining response to controlled ovarian stimulation for in vitro fertilisation. In Templeton, A., Cooke, I. and Shaughn O'Brien, P.M. (eds), Evidence-based fertility treatment. RCOG Press, London, pp. 274-282.
7. Barnes, F.L., Kausche, A., Tiglias, J. et al. (1996) Production of embryos from in vitro-matured primary human oocytes. Fertil. Steril. 65, 1151-1156.
8. Belaisch-Allart, J., de Mouzon, J., Lapousterle, C. and Mayer, M. (1990) The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme. Hum. Reprod. 5, 163-166.
9. Ben Rafael, Z., Strauss, J.F.I.I.I., Mastroianni, L.J. and Flickinger, G.L. (1986) Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulation. Fertil. Steril. 46, 586-592.
10. Bristow, R.E. and Karlan, B.Y. (1996) Ovulation induction, infertility, and ovarian cancer risk. Fertil. Steril. 66, 499-507.
11. Bronson, R. (1997) Embryo transfer and multiple gestation. Hum. Reprod. 12, 1605-1606.
12. Callahan, T.L., Hall, J.E., Ettner, S.L. et al. (1994) The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N. Engl. J. Med. 331, 244-249.
13. Center for Disease Control and Prevention (1998) 1995 ART pregnancy success rates. www2.cdc.gov/nccdphp/invitro/nation.asp. World Wide Web
14. Cha, K.Y. and Chian, R.C. (1998) Maturation in vitro of immature human oocytes for clinical use. Hum. Reprod. Update. 4, 103-120.
15. Chikazawa, K., Araki, S. and Tamada, T. (1986) Morphological and endocrinological studies on follicular development during the human menstrual cycle. J. Clin. Endocrinol. Metab. 62, 305-313.
16. De Jong, D., Macklon, N.S. and Fauser, B.C. (1999) Minimal ovarian stimulation for IVF: extending the follicle-stimulating hormone window. In Jansen, R.P. and Mortimer, D. (eds.), Towards Reproductive Certainty: Fertility and Genetics beyond 1999. Parthenon Publishing, London, pp. 195-199.
17. de Mouzon, J. and Lancaster, P. (1997) World collaborative report on in vitro fetilization. Preliminary data from 1995. J. Assist. Reprod. Genet. 5 (Suppl.), 251S-265S.
18. de Ziegler, D., Jaaskelainen, A.S., Brioschi, P.A. et al. (1998) Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation. Hum. Reprod. 13, 561-564.
19. Diedrich, K. and Felberbaum, R. (1998) New approaches to ovarian stimulation. Hum. Reprod., 13 (Suppl. 3), 1-13.
20. Diedrich, K., Diedrich, C., Santos, E. et al. (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum. Reprod. 9, 788-791.
21. Dong, J., Albertini, D.F., Nishimori, K. et al. (1996) Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature, 383, 531-535.
22. Edwards, R.G., Lobo, R. and Bouchard, P. (1996) Time to revolutionize ovarian stimulation. Hum. Reprod. 11, 917-918.
23. Elchalal, U. and Schenken, J.G. (1997) The pathophysiology of ovarian hyperstimulationsyndrome -views and ideas. Hum. Reprod. 12, 1129-1137.
24. Fauser, B.C.J.M. and van Heusden, A.M. (1997) Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr. Rev. 18, 71-106.
25. FIVNAT (1995) Pregnancies and birth resulting from in vitro fertilization: French national registry, analysis of data 1986 to 1990. Fertil. Steril. 64, 746-756.
26. FIVNAT (1996) Bilan FIVNAT 1995. Contracept. Fertil. Sex. 24, 694-699.
27. Foulot, H., Ranoux, C., Dubuisson, J.B. et al. (1989) In vitro fertilization without ovarian stimulation: A simplified protocol applied in 80 cycles. Fertil. Steril. 52, 617-621.
28. Frydman, R., Cornel, C., de Ziegler, D. et al. (1991) Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation. Fertil. Steril. 56, 923-927.
29. Gardner, D.K. and Lane, M. (1997) Culture and selection of viable blastocysts: a feasible proposition for human IVF? Hum. Reprod. Update. 3, 367-382.
30. Gardner, D.K., Vella, P., Lane, M. et al. (1998) Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfer. Fertil. Steril. 69, 84-88.
31. Gougeon, A. (1996) Regulation of ovarian follicular development in primates: Facts and hypothesis. Endocr. Rev. 17, 121-155.
32. Groome, N.P., Illingworth, P.J., O'Brien, M. et al. (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 81, 1401-1405.
33. Hall, J.E. (1993) Gonadotropin-releasing hormone antagonists: Effects on the ovarian follicle and corpus luteum. Clin. Obstet. Gynecol. 36, 744-752.
34. Hillier, S.G., Afnan, A.M., Margara, R.A. and Winston, R.M. (1985) Superovulation strategy before in vitro fertilization. Clin. Obstet. Gynaecol. 12, 687-723.
35. Hodgen, G.D. (1982) The dominant ovarian follicle. Fertil. Steril. 38, 281-300.
36. Hsueh, A.J., Eisenhauer, K., Chun, S.Y. et al. (1996) Gonadal cell apoptosis. Rec. Progr. Horm. Res, 51, 433-455.
37. Hugues, J.N. and Cedrin-Durnerin, I. (1998) Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins. Hum. Reprod. Update. 4, 83-101.
38. ISLAT working group. (1998) ART into science: Regulation of fertility techniques. Science, 281, 651-652.
39. Jones, H.W., Jr, Out, H.J., Hoomans, E.H. et al. (1997) Cryopreservation: the practicalities of evaluation. Hum. Reprod. 12, 1522-1524.
40. Kananen, K., Rilianawati, K.K., Paukku, T. et al. (1997) Suppression of gonadotropins inhinits gonadal tumorigenesis in mice transgenic for the mouse inhibin α-subunit promotor/simian virus 40 large T-antigen fusion gene. Endocrinol. 138, 3521-3531.
41. Kumar, T.R., Wang, Y. and Matzuk, M.M. (1996) Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice. Endocrinol. 137, 4210-4216.
42. Lenton, E.A., Cooke, I.D., Hooper, M. et al. (1992) In vitro fertilization in the natural cycle. Baill. Clin. Obstet. Gynaecol. 6, 229-245.
43. MacDougall, M.J., Tan, S.L., Balen, A. and Jacobs, H.S. (1993) A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum. Reprod. 8, 233-237.
44. Mandelbaum, J., Belaisch-Allart, J., Junca, A.M. et al. (1998) Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes. Hum. Reprod. 13 (Suppl. 3), 161-177.
45. McNatty, K.P., Hillier, S.G., van den Boogaard, A.M. et al. (1983) Follicular development during the luteal phase of the human menstrual cycle. J. Clin. Endocrinol. Metab. 56, 1022-1031.
46. Muasher, S.J. (1998) Clinical specific success rate reporting: Let us not fool our patients and ourselves. ASRM News, 21-22.
47. Oehninger, S. and Hodgen, G.D. (1990) Induction of ovulation for assisted reproduction programmes. Baillieres. Clin. Obstet. Gynaecol. 4, 541-573.
48. Oktay, K., Briggs, D. and Gosden, R.G. (1997) Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J. Clin. Endocrinol. Metab. 82, (11):3748-51.
49. Oktay, K., Newton, H., Aubard, Y. et al. (1998) Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology? Fertil. Steril. 69, 1-7.
50. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1996) Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a gnrh antagonist. Fertil. Steril. 66, 151-153.
51. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1995) Scheduled administration of a gonadotrophin-releasing hormone antagonist (cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum. Reprod, 10, 1382-1386.
52. Olivennes, F. and Frydman, R. (1998) Friendly IVF: the way of the future? Hum. Reprod. 13, 1121-1124.
53. Pache, T.D., Wladimiroff, J.W., De Jong, F.H. et al. (1990) Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil. Steril. 54, 638-642.
54. Perez, G.I., Robles, R., Knudsen, C.M. et al. (1999) Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat. Genet. 21, 200-203.
55. Porcu, E., Fabbri, R., Seracchioli, R. et al. (1998) Birth of six healthy children after intracytoplasmic sperm injection of cryopreserved human oocytes. Annual Meeting European Society of Human Reproduction, O-240. 124
56. Porcu, E., Fabbri, R., Seracchioli, R. et al. (1999) Birth of a healthy female after intracytplasmic sperm injection of cryopreserved human oocytes. Fertil. Steril. 68, 724-726.
57. Risma, K.A., Clay, C.M., Nett, T.M. et al. (1995) Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl. Acad. Sci. U. S. A, 92, (5):1322-6.
58. Rombauts, L., Suikkari, A.M., MacLachlan, V. et al. (1998) Recruitment of follicles by recombinant follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil. Steril. 69, 665-669.
59. Rongieres-Bertrand, C., Olivennes, F., Righini, C. et al. (1999) Revival of the natural cycle in in vitro fertilization with use of a new GnRH antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum. Reprod. 14, 683-688.
60. Schenker, J.G. and Ezra, Y. (1994) Complications of assisted reproductive techniques. Fertil. Steril. 61, 411-122.
61. Schipper, I., Hop, W.C. and Fauser, B.C. (1998) The follicle-stimulating hormone (fsh) threshold/window concept examined by different interventions with exogenous fsh during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of fsh increase affects follicle development. J Clin. Endocrinol. Metab. 83, (4):1292-8.
62. Scholtes, M.C. and Zeilmaker, G.H. (1996) A prospective, randomized study of embryo transfer results after 3 or 5 days of embryo culture in in vitro fertilization. Fertil. Steril. 65, 1245-1248.
63. Seibel, M.M. (1994) The natural cycle for in vitro fertilization. In Seibel, M.M. and Blackwell, R.E. (eds.), Ovulation induction. Raven Press, New York, pp. 223-228.
64. Seifer, D.B., Lambert-Messerlian, G.M., Hogan, J.W. et al. (1997) Day 3 serum inhibin-B predictive of assisted reproduction technologies outcome. Fertil. Steril. 67, 110-114.
65. Shoham, Z. (1994) Epidemiology, etiology and fertility drugs in ovarian epithelial carcinoma: Where are we today? Fertil. Steril. 62, 433-448.
66. Simoon, C., Garcia Velasco, J.J., Valbuena, D. et al. (1998) Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil. Steril. 70, 234-239.
67. Smitz, J., DeVroey, P., Braeckmans, P. et al. (1987) Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Hum. Reprod. 2, 309-314.
68. Society for Assisted Reproductive Technology (1996) Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society of Reproductive Medicine/Society for Assisted Reproductive Technology registry. Fertil. Steril. 66, 697-705.
69. Society for Assisted Reproductive Technology (1999) Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry. Fertil. Steril. 71, 798-807.
70. Sullivan, M.W., Stewart-Akers, A., Krasnow, J.S. et al. (1999) Ovarian responses in women to recombinant FSH and LH: a role for LH in the final stages of follicular maruration. J. Clin. Endocrinol. Metab., 84, 228-232.
71. Templeton, A., Morris, J.K. and Parslow, W. (1996) Factors that affect outcome of in-vitro fertilisation treatment. Lancet. 348, (9039):1402-6.
72. Templeton, A. and Morris, J.K. (1998) Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization. N. Engl. J. Med. 339, 573-577.
73. van Dessel, H.J.H.M., Schipper, I., Pache, T.D. et al. (1996) Normal human follicle development: An evaluation of correlations with oestradiol, and rostenedione and progesterone levels in individual follicles. Clin. Endocrinol. (Oxf) 44, 191-198.
74. van Hooff, M.H., Alberda, A.T., Huisman, G.J. et al. (1993) Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Hum. Reprod. 8, 369-373.
75. van Santbrink, E.J.P., van Dessel, H.J.H.M., Hop, W.C. et al. (1995) Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil. Steril. 64, 37-43.
76. Vilska, S., Tiitinen, A., Hyden-Granskog, C. and Hovatta, O. (1998) Elective transfer of one embryo results in an acceptable pregnancy rate and eliminates the risk of multiple birth. Annual Meeting European Society of Human Reproduction, 148
77. Wolner-Hanssen, P. and Rydhstroem, H. (1998) Cost-effectiveness analysis of in-vitro fertilization: estimated costs per successful pregnancy after transfer of one or two embryos. Hum. Reprod. 13, 88-94.
78. Zeleznik, A.J. (1993) Dynamics of human follicle growth: A physiologic perspective. In Adashi, E.Y. and Leung, P.C.K. (eds), The Ovary. Raven Press, New York, pp. 41-56.